Taille des projets
WHO-GMP certified pharmaceutical manufacturing facility producing essential medicines for West African market
Résumé rapide
Integrated plant producing tablets, capsules, and injectables with capacity for export
Mise en place du projet
Informations sur le projet
Type: Greenfield Project
Stage: Concept Stage
Détails de la révocation
Country: Nigeria
Specific Location: Lagos State, Nigeria
Innovation numérique et Fintech
$30M – $45M
Fourchette d’investissement
21,00%
Rendements attendus
Période de récupération
5
Incitations et soutien à l'investissement
Des informations détaillées sur les incitations sont disponibles auprès de l’Agence de promotion des investissements. Veuillez les contacter directement pour connaître les derniers packages d’incitation.
Informations sur la localisation
Description
Country: Nigeria
Specific Location: Lagos State, Nigeria
Lien optionnel vers la page concernée
- Passerelle stratégique vers l'Afrique de l'Ouest
- Access to Nigeria market
- Couverture régionale de la CEDEAO
Évaluation des risques
Foire aux questions
The investment approval process typically involves application submission to the IPA,
project evaluation, regulatory approvals, and final licensing. Contact the IPA for
specific requirements and timelines.
Nigeria offers various investment incentives including
tax holidays, duty exemptions, and other fiscal incentives. Contact the IPA for a complete
incentive package tailored to your investment.
Foreign ownership rules vary by sector. Nigeria
generally allows 100% foreign ownership in most sectors. Contact the IPA for sector-specific
requirements and any local partnership obligations.
The implementation timeline depends on project complexity, approvals, and construction.
Contact the IPA for a detailed project timeline and milestone schedule.
